FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000620721> ?p ?o ?g. }

• W2000620721 endingPage "1163" @default.
• W2000620721 startingPage "1149" @default.
• W2000620721 abstract "This randomized study evaluated the combined effect of a cognitive-communication program plus an acetylcholinesterase inhibitor (donepezil; donepezil-plus-stimulation group; n = 26), as compared with donepezil alone (donepezil-only group; n = 28) in 54 patients with mild to moderate Alzheimer’s disease (AD; Mini-Mental Status Examination score of 12– 28) ranging in age from 54 to 91 years. It was hypothesized that cognitive-communication stimulation in combination with donepezil would positively affect the following: (a) relevance of discourse, (b) performance of functional abilities, (c) emotional symptoms, (d) quality of life, and (e) overall global function, as measured by caregiver and participant report and standardized measures. Cognitive-communication, neuropsychiatric, functional performance, and quality of life evaluations were conducted at baseline and Month 4, the month after the 2-month active stimulation period. Follow-up evaluations were performed at Months 8 and 12. The stimulation program consisted of 12 hr of intervention over an 8-week period and involved participant-led discussions requiring homework, interactive sessions about AD, and discussions using salient life stories. Additive effects of active stimulation with donepezil were examined in 2 ways: (1) comparing mean group performance over time and (2) evaluating change scores from baseline. A Group x Time interaction was found for the donepezil-plus-stimulation group in the emotional symptoms of apathy and irritability as compared with the donepezil-only group. Evaluation of change scores from baseline to 12 months revealed a positive effect for the donepezil-plus-stimulation group on discourse and functional abilities with a trend on apathy, irritability, and patient-reported quality of life. In sum, the research revealed benefits to the donepezil-plus-stimulation group in the areas of discourse abilities, functional abilities, emotional symptoms, and overall global performance. This study adds to growing evidence that active cognitive stimulation may slow the rate of verbal and functional decline and decrease negative emotional symptoms in AD when combined with acetylcholinesterase inhibitors, indicating a need to advance research in the area of cognitive treatments. The fact that AD is a progressive brain disease should not preclude ameliorative treatment." @default.
• W2000620721 created "2016-06-24" @default.
• W2000620721 creator A5024810489 @default.
• W2000620721 creator A5044324548 @default.
• W2000620721 creator A5047313225 @default.
• W2000620721 creator A5052470764 @default.
• W2000620721 creator A5054642380 @default.
• W2000620721 date "2004-10-01" @default.
• W2000620721 modified "2023-09-27" @default.
• W2000620721 title "Effects of Cognitive-Communication Stimulation for Alzheimer’s Disease Patients Treated With Donepezil" @default.
• W2000620721 cites W1164896577 @default.
• W2000620721 cites W1847168837 @default.
• W2000620721 cites W1964351497 @default.
• W2000620721 cites W1991952617 @default.
• W2000620721 cites W1996776294 @default.
• W2000620721 cites W1998896869 @default.
• W2000620721 cites W2001469954 @default.
• W2000620721 cites W2007153152 @default.
• W2000620721 cites W2010092992 @default.
• W2000620721 cites W2013864471 @default.
• W2000620721 cites W2020893503 @default.
• W2000620721 cites W2030633557 @default.
• W2000620721 cites W2047095305 @default.
• W2000620721 cites W2052162675 @default.
• W2000620721 cites W2057679568 @default.
• W2000620721 cites W2057745513 @default.
• W2000620721 cites W2061545994 @default.
• W2000620721 cites W2063753762 @default.
• W2000620721 cites W2067300476 @default.
• W2000620721 cites W2083642947 @default.
• W2000620721 cites W2087604101 @default.
• W2000620721 cites W2092844477 @default.
• W2000620721 cites W2099961158 @default.
• W2000620721 cites W2109941965 @default.
• W2000620721 cites W2110095166 @default.
• W2000620721 cites W2111963393 @default.
• W2000620721 cites W2120673592 @default.
• W2000620721 cites W2130900065 @default.
• W2000620721 cites W2133223533 @default.
• W2000620721 cites W2141838737 @default.
• W2000620721 cites W2148600530 @default.
• W2000620721 cites W2149393453 @default.
• W2000620721 cites W2156220037 @default.
• W2000620721 cites W2158766477 @default.
• W2000620721 cites W2327349711 @default.
• W2000620721 cites W2415750758 @default.
• W2000620721 cites W2464068509 @default.
• W2000620721 doi "https://doi.org/10.1044/1092-4388(2004/085)" @default.
• W2000620721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15603468" @default.
• W2000620721 hasPublicationYear "2004" @default.
• W2000620721 type Work @default.
• W2000620721 sameAs 2000620721 @default.
• W2000620721 citedByCount "128" @default.
• W2000620721 countsByYear W20006207212012 @default.
• W2000620721 countsByYear W20006207212013 @default.
• W2000620721 countsByYear W20006207212014 @default.
• W2000620721 countsByYear W20006207212015 @default.
• W2000620721 countsByYear W20006207212016 @default.
• W2000620721 countsByYear W20006207212017 @default.
• W2000620721 countsByYear W20006207212018 @default.
• W2000620721 countsByYear W20006207212019 @default.
• W2000620721 countsByYear W20006207212020 @default.
• W2000620721 countsByYear W20006207212021 @default.
• W2000620721 countsByYear W20006207212022 @default.
• W2000620721 countsByYear W20006207212023 @default.
• W2000620721 crossrefType "journal-article" @default.
• W2000620721 hasAuthorship W2000620721A5024810489 @default.
• W2000620721 hasAuthorship W2000620721A5044324548 @default.
• W2000620721 hasAuthorship W2000620721A5047313225 @default.
• W2000620721 hasAuthorship W2000620721A5052470764 @default.
• W2000620721 hasAuthorship W2000620721A5054642380 @default.
• W2000620721 hasConcept C118552586 @default.
• W2000620721 hasConcept C126322002 @default.
• W2000620721 hasConcept C138496976 @default.
• W2000620721 hasConcept C15744967 @default.
• W2000620721 hasConcept C169760540 @default.
• W2000620721 hasConcept C169900460 @default.
• W2000620721 hasConcept C24998067 @default.
• W2000620721 hasConcept C2779134260 @default.
• W2000620721 hasConcept C2779483572 @default.
• W2000620721 hasConcept C2779951463 @default.
• W2000620721 hasConcept C2780904820 @default.
• W2000620721 hasConcept C542102704 @default.
• W2000620721 hasConcept C548259974 @default.
• W2000620721 hasConcept C71924100 @default.
• W2000620721 hasConceptScore W2000620721C118552586 @default.
• W2000620721 hasConceptScore W2000620721C126322002 @default.
• W2000620721 hasConceptScore W2000620721C138496976 @default.
• W2000620721 hasConceptScore W2000620721C15744967 @default.
• W2000620721 hasConceptScore W2000620721C169760540 @default.
• W2000620721 hasConceptScore W2000620721C169900460 @default.
• W2000620721 hasConceptScore W2000620721C24998067 @default.
• W2000620721 hasConceptScore W2000620721C2779134260 @default.
• W2000620721 hasConceptScore W2000620721C2779483572 @default.
• W2000620721 hasConceptScore W2000620721C2779951463 @default.
• W2000620721 hasConceptScore W2000620721C2780904820 @default.
• W2000620721 hasConceptScore W2000620721C542102704 @default.
• W2000620721 hasConceptScore W2000620721C548259974 @default.

• next